TfR mAb-Cross-Linked Rituximab/MTX-PEG-PLL-PLGA Drug-Loaded Nanoparticles Enhance Anticancer Action in B Lymphocytes

Figure 6

Cell apoptosis analysis of SU-DHL-4 cells treated by different kinds of drug for 48 hours using flow cytometry with PI and FITC-Annexin V staining.